Bayan Health vs NuuVim
Neither of these is a month you can walk away from after thirty days, and the lower figure buys a deliberately smaller protocol rather than the standard dose.
Bayan Health
Editorial
$119/mo
The $129 semaglutide and $149 tirzepatide lines are the standard weekly doses; the cheaper figures on the site are separate microdose products. Every weight-management plan carries a 90-day commitment that cannot be canceled, on a site whose FAQ says plans can be canceled at any time.
- No membership fee and no dose-based price increase
- The consultation fee schedule is published and stated as included
- Four GLP-1 formats are priced on the page rather than behind an intake
- The clinician network is named
- The headline figure is a microdose; the standard doses cost more
- A 90-day commitment cannot be canceled once started
- No pharmacokinetic data is published for the oral drop route
- The compounding pharmacies are not named
Pick it for: A deliberately smaller dose you have chosen on purpose
Not for: Anyone who may need to cancel inside three months.
NuuVim
Editorial
$199.67/mo
The advertised rate covers the first three months only, and the standard semaglutide rate NuuVim publishes in the next column of the same card is $133 a month, billed as one three-month payment rather than monthly. One price applies at every dose, stated on each card, with free shipping and no membership fee.
- Introductory and standing rates published side by side
- One price at every dose, stated on every card
- Two partner pharmacies named with street addresses
- Free shipping and no membership fee
- The advertised figure covers only the first three months
- Billing is one three-month payment, not monthly
- Marketing repeats the introductory rate, not the standing one
- Fees paid before cancellation are non-refundable
Pick it for: A flat rate that never moves as the dose climbs
Not for: Anyone who needs to pay month by month.
Our verdict
Bayan's tirzepatide drops are its microdose line; the standard weekly dose is a separate product, and no pharmacokinetic data is published for the sublingual route, so what actually reaches the bloodstream is unstated. Every Bayan weight-management plan also carries a 90-day commitment that cannot be canceled, which puts the smallest real outlay on the drops at $357. NuuVim locks in the same three months a different way: one payment of $599 a cycle, at one rate for every dose.
What actually separates them
Bayan Health and NuuVim differ on published price, names its pharmacy and where you can use it. The table summarizes those terms; confirm any details it does not cover with the provider.
NuuVim’s comparison figure is $80.67 higher than Bayan Health’s — a 68% difference between the listed rates. These figures do not establish equivalent prescribed doses, supply or care. Confirm the selected product, full payment obligation and next charge.
At unchanged rates, a twelve-month illustration is about $1,428 at Bayan Health against $2,396 at NuuVim — a difference of $968. This is not a quote for a year of care: actual charges depend on prescribed supply, purchase terms and renewals.
| Bayan Health | NuuVim | |
|---|---|---|
| Published price | $119/mo | $199.67/mo |
| Names its pharmacy | No | Yes |
| Where you can use it | Nationwide; no state list published | 50 states plus DC |
What neither of them tells you
A comparison that only reports differences implies everything else is settled. Here it is not.
- Neither publishes a milligram dose, so neither price can be compared with the other — or with anything else.
Before you choose either
Neither of these sellers publishes a milligram dose, so neither price can be compared with the other or with anything else — which is normal in this category and is exactly the problem. Ask both what dose the monthly price buys, and see the sellers that do publish one before you assume the cheaper sticker is the cheaper product.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.